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ABSTRACT
The BioHealthBase Bioinformatics Resource Center
(BRC) (www.biohealthbase.org) is a public bio-
informatics database and analysis resource for the
study of specific biodefense and public health
pathogens—Influenza virus, Francisella tularensis,
Mycobacterium tuberculosis, Microsporidia species
and ricin toxin. The BioHealthBase serves as an
extensive integrated repository of data imported
from public databases, data derived from various
computational algorithms and information curated
from the scientific literature. The goal of the
BioHealthBase is to facilitate the development of
therapeutics, diagnostics and vaccines by integrat-
ing all available data in the context of host–
pathogen interactions, thus allowing researchers
to understand the root causes of virulence and
pathogenicity. Genome and protein annotations can
be viewed either as formatted text or graphically
through a genome browser. 3D visualization cap-
abilities allow researchers to view proteins with key
structural and functional features highlighted.
Influenza virus host–pathogen interactions at
the molecular/cellular and systemic levels are
represented. Host immune response to influenza
infection is conveyed through the display of experi-
mentally determined antibody and T-cell epitopes
curated from the scientific literature or as derived
from computational predictions. At the molecular/
cellular level, the BioHealthBase BRC has develo-
ped biological pathway representations relevant
to influenza virus host–pathogen interaction in
collaboration with the Reactome database
(www.reactome.org).
INTRODUCTION
Seasonal ﬂu is an acute viral infection generally involving
the upper respiratory tract that aﬀects 5–20% of the
human population resulting in the death of 35000
people each year in the US. Although mortality rates from
ﬂu are typically low (<0.1%) (1), three times during the
last century an especially virulent form of the disease
emerged, resulting in pandemics. In 1918, the Spanish ﬂu
(subtype H1N1) swept across Europe and the United
States causing 40–50 million deaths (2). In 1957 and 1968,
the Asian ﬂu (H2N2) and Hong Kong ﬂu (H3N2) claimed
1 million lives each.
Influenza structure
In order to understand, and ultimately prevent, the
emergence of these deadly pandemics it is essential to
understand the key characteristics of the etiologic agent
and the nature of how it interacts with its hosts at the
molecular level. Inﬂuenza virus is a member of the
Orthomyxoviridae family of segmented negative single-
stranded RNA viruses. The genome of Inﬂuenza A virus is
composed of eight RNA segments, which together encode
11 functional polypeptides (3). Many of the inﬂuenza virus
proteins contribute to the virus host range. The PA, PB1,
PB2 and NP proteins form an RNA polymerase complex
responsible for viral RNA replication and transcription.
The NP protein also coats the viral RNA genome
segments to form the ribonucleoprotein (RNP) core. The
HA protein facilitates virion binding to sialic acid
glycolipids on the host cell’s plasma membrane and also
*To whom correspondence should be addressed. Tel: +1 214 648 4115; Fax: +1 214 648 4070; Email: richard.scheuermann@utsouthwestern.edu
 2007 The Author(s)
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/2.0/uk/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.facilitates endosome fusion through an acid-induced
conformation change mechanism. The NA protein facil-
itates virion release through its neuraminidase activity.
The NS1 protein plays a critical role in facilitating viral
replication by inhibiting the host immune response to viral
infection. The remaining proteins M1, M2 and NS2
function as structural proteins while PB1-F2 assists in
apoptosis.
Host range
As a species, inﬂuenza virus can infect a variety of
mammalian and non-mammalian hosts, including wild
and domesticated birds, pigs and humans. However,
individual viral isolates exhibit more selective host range
preferences (4). Host-range speciﬁcity appears to be partly
dictated by the complementarities between variants of the
viral HA proteins and the structure of the sialic acid on
the host cell surface (5). More recently, other inﬂuenza
proteins have also been found to inﬂuence host range
to varying degrees.
Viral evolution
While inﬂuenza virus has developed a variety of mechan-
isms to dampen the initial immune response to viral
infection, the virus is ultimately eliminated through a
combination of innate and adaptive immune responses (6).
But if protective immunity against inﬂuenza is routinely
elicited, why are we susceptible to the disease each year,
and how does a pandemic strain emerge on occasion?
The answers to these questions relate to the nature and
evolution of the viral genome, and two phenomena of HA
variation—antigenic drift and antigenic shift (7).
As with all other species, inﬂuenza evolves through
a process of mutation and selection. Mutations that result
in the retention of the structural and biochemical
functions of the viral proteins while simultaneously
destroying antigenic determinants previously recognized
by the adaptive immune system. Thus, a large pool of
sequence variants is available for selection because the
viral RNA-directed RNA polymerase lacks an editing
function. This selection for minor variations in HA
sequence has been termed antigenic drift. While this drift
is suﬃcient to allow the virus to evade a robust adaptive
immune response each ﬂu season, it also may limit the
ability of the virus to develop highly virulent variants
during transmission within a particular host species.
In contrast, the emergence of pandemic strains has been
associated with major HA sequence variations—antigenic
shift—which appear to occur when a single host cell is
co-infected with diﬀerent viral strains resulting in virions
that contain a variety of new assortments of the eight viral
segments derived from diﬀerent source viruses. It has been
hypothesized that reassortment of genome segments may
occur in species, like pig, with cells that present sialic acid
with both the avian alpha 2,3 and human alpha 2,6
linkages. This could provide a mechanism for one viral
clade to evolve through antigenic drift in one species
where it develops the characteristics of a highly virulent
strain for another species before crossing the species
barrier following an antigenic shift event.
Influenza information management
Clearly, a detailed understanding of the interactions
between virus and host would not only help us to
understand the emergence of disease outbreaks, but also
facilitate the development of improved diagnostics,
therapeutics and vaccines to prevent and control inﬂuenza
infection. A resource that goes beyond traditional
bioinformatics is necessitated, and, if well constructed,
would positively impact disparate ﬁelds in public health,
molecular biology, life science information management
and clinical studies. We aimed to create such a resource.
Many national and international health organizations
have invested substantial resources in the support of
research focused on improving our understanding of the
pathogenesis of human infectious diseases. To bring
together information from this valuable research, the
National Institute of Allergy and Infectious Diseases
recently funded the development of eight Bioinformatics
Resource Centers for Biodefense and Emerging/Re-
emerging Infectious Diseases (BRCs; www.brc-central.
org/) focused on Category A–C pathogens (8). The
BioHealthBase BRC is responsible for supporting data
related to a select subset of these pathogens including
inﬂuenza virus. The BioHealthBase BRC has assembled
and integrated a variety of diﬀerent types of data related
to inﬂuenza virus, including gene and protein structure
and function, sequence variation and immunological
epitope information. In this manuscript, we describe
the use of the BioHealthBase BRC to investigate the
determinants of virulence in variant strains of avian H5N1
clade viruses, which are of special concern as a potential
source for the next human pandemic strain.
DESCRIPTION
As of August 2007, information about 13000 inﬂuenza
virus strains is available at the BioHealthBase BRC. The
BioHealthBase has been built upon a comprehensive
foundation of gene and protein structure and function
data from numerous external sources, including the
NCBI, UniProt and the Immune Epitope Database
(IEDB) (www.immuneepitope.org) (9) (Supplementary
Figure 1A). The BHB support team derives and integrates
novel data through the application of predictive bio-
informatics algorithms and custom BHB-developed pipe-
lines to primary sequence and annotation data for
the pathogens under study. These data include immune
epitopes, protein and RNA structures and protein
localizations and genome sequence variations
(Supplementary Figure 1B). The integration of available
external data with information derived from computa-
tional prediction algorithms and manual curation pro-
vides a comprehensive framework to address scientiﬁc
issues related to pathogen virulence.
In order to further understand the complexities of
host–pathogen interactions, the BioHealthBase has con-
tributed to the development of a comprehensive inﬂuenza
life cycle within the Reactome database (10) project and is
currently assisting in the completion of the inﬂuenza life
cycle pathway details. A complete representation of the
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for viral replication and the host response to infection can
be used for predicting targets for antiviral drugs and for
determining the nature of virulence associated with
protein sequence variants.
Scientific usecases: the Guangxi/35 example
To drive development of the BioHealthBase system, we
have utilized scientiﬁc use cases to help deﬁne relevant
data types, storage and query function and informatics
processing workﬂows. For example, in 2005, Li et al. (11)
described an analysis of H5N1 isolates obtained from
healthy ducks in southern China, which varied in their
ability to cause lethal infections in mice, with A/duck/
Guangxi/22/2001 (DkXi22) being relatively avirulent
and A/duck/Guangxi/35/2001 (DkXi35) being highly
virulent. Using reverse genetic approaches, they found
that virulence was partly dictated by the presence of Asn
instead of Asp at position 701 of the PB2 protein.
However, diﬀerence in other viral proteins, including
NS1, also appeared to be involved. Utilizing the sequence
data within the BioHealthBase, we will examine the
additional causes of virulence of the DkXi35 strain.
Sequence search
We begin by utilizing the sequence search page speciﬁcally
tailored for inﬂuenza virus-related data to examine these
two strains in greater detail. Links to this search page
are found along the upper left side of the BioHealthBase
webpage. Simple keyword searches or advanced searches
based on speciﬁc sequence annotation features
(Figure 1A) may be performed on the inﬂuenza sequence
search page. To ﬁnd sequence records related to the
DkXi35 strain, we searched for inﬂuenza A virus
sequences of subtype H5N1 isolated from an avian host
in China during the year 2001. The search page is also
capable of excluding particular records by subtype, host,
country and date range if necessary.
We now turned our attention to the PB2 proteins of
the selected strains. By selecting the protein data type,
the sequence search page enables the selection of one or
more proteins as well as limiting a search to full-length
sequences or sequences belonging to a completely
sequenced genome. By default searches include partial
and full-length sequences and are not restricted to
complete genome sets. Since we are only interested in
full-length protein PB2 records, we select the full-length
CDS option. We then select what sequence features to
display in the search results and how the results records
should be ordered (e.g. sort by strain name then segment).
The search returns 10 PB2 results including the DkXi22
and DkXi35 PB2 proteins (Figure 1B). By selecting one or
more of the search results one is able to perform a variety
of actions including downloading search results, or
selected sequences in GFF3 or FASTA format or adding
the sequences to a GeneCart (see later) for further
analysis. Following the link from a record’s gene symbol
or protein name allows us to view the details of a
particular sequence record. The Gene Details page
contains all of the annotation integrated from external
sources or computed internally for the selected sequence
(Figure 1C). In the case of DkXi35, the annotation feature
of particular interest is the single nucleotide polymorph-
ism (SNP) annotation. For each gene (e.g. PB2) and
species subtype (e.g. avian H5N1) a consensus sequence is
computed. Each sequence is then compared to the
consensus sequence and polymorphisms are identiﬁed
using custom perl scripts. In summary, our analysis
yielded 14nt substitutions in the DkXi35 strain’s PB2
gene, in comparison with the avian H5N1 consensus.
Sequenceanalysis using GeneCart
The BioHealthBase can save search results to a temporary
workspace or ‘GeneCart’ for further analysis. In our use
case, we save the DkXi22, DkXi35 and related PB2
sequences to the GeneCart. Additional sequence records
derived from other searches can also be added. The
GeneCart augments the sequence search capability of the
BioHealthBase by allowing the assembly of disparate sets
of sequences, which would be diﬃcult to gather using
a single search alone.
Once sequences have been added to the GeneCart they
may be downloaded in FASTA or GFF3 format. The real
power of the GeneCart is the ability to seamlessly perform
BLAST analysis or multiple sequence alignment on one or
more of the sequences in the GeneCart. For our analysis,
we are interested in aligning the PB2 sequences as
displayed in Figure 2A as well as the NS1 sequences as
shown in Figure 2B. Multiple sequence alignment is
performed using the MUSCLE (12) algorithm. Navigating
to the multiple sequence alignment tool page from the
GeneCart automatically populates the selected sequences
into the sequence ﬁeld for quicker alignments.
Sequencefeature visualization
In addition to the textual view of the Gene Details page
sequences in the BioHealthBase can also be viewed in a
2D genome browser based on the GBrowse application
(13). Sequence feature annotations are contained in
‘tracks’ that may be customized for viewing by turning
them oﬀ or on or by re-conﬁguring them. A user can also
upload personal tracks of formatted annotation data. In
our case, we can see that the NS1 segment contains 7-nt
substitutions in comparison with the avian H5N1 con-
sensus sequence, and two of these substitutions (colored in
red) reﬂect amino acid changes that overlap with NetCTL
(14) predicted T-cell epitopes of the human HLA A2
supertype (Figure 3).
Proteinstructural analysis
Finally, the BioHealthBase was used to visualize the
physical relationship between the amino acid sequence
variations in NS1 and the known functional regions of the
protein using a 3D protein structure visualization window
accessible through the left-hand menu. Proteins can be
viewed in this tool in a variety of display formats (e.g. ball-
and-stick, space-ﬁlling, ribbon) and diﬀerent structural
and functional regions highlighted. The viewer is based on
a custom Jmol (www.jmol.org) implementation loaded
with data from the Protein Database (15). In this use case,
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onto the structure determined for the RNA-binding
domain of the NS1 protein from the A/Udorn/307/1972
isolate (Figure 4). From this analysis, it is clear that the
amino acid sequence variation found in this region of the
DkXi35 NS1 protein (G66E) is structurally distinct from
the key RNA contact residues (aa38 and aa41), and is well
outside of the RNA-binding pocket. Thus, this compara-
tive analysis between sequence polymorphic variations
and protein structural regions suggests that it is unlikely
that the G66E variation inﬂuences virulence by aﬀecting
NS1–RNA interactions.
CONCLUSIONS
The BioHealthBase BRC provides a portal to a
comprehensive range of biological data related to
Figure 1. Query access to annotation data. Screenshot of use case query/search page (A), summary results (B) and gene details for PB2 Quangxi/35
(C) are shown. Query constraint and report options and annotation details are described in more detail in the text.
D500 Nucleic Acids Research, 2008, Vol. 36, DatabaseissueFigure 2. Protein sequence alignment. The PB2 (A) and NS1 (B) protein sequences from all 10 inﬂuenza A virus H5N1 duck sequences isolated in
China during 2001 were aligned separately using the BioHealthBase implementation of the MUSCLE algorithm. Only the PB2 protein region from
aa661 to aa759 and the NS1 protein region from aa1 to aa120 are shown. The key N701D substitution found to aﬀect virulence in DkXi35 PB2 and
the G66E diﬀerence between DkXi22 and DkXi35 in the NS1 RNA-binding domain are highlighted.
Figure 3. Genome structure view of DkXi35 segment 8. The RNA segment encoding the NS1 protein from A/duck/Guangxi/35/2001, the sequence
variations versus the avian H5N1 consensus sequences and A2 supertype epitopes predicted by the NetCTL algorithm are shown.
Nucleic Acids Research, 2008,Vol. 36,Database issue D501inﬂuenza virus physiology and pathogenesis. While
several public database resources provide focused
data sets about inﬂuenza virus isolates (e.g. sequence
records), the BioHealthBase emphasizes the integration
of data from public resources together with data
derived from various analysis and prediction algorithms,
allowing researchers to explore hypotheses using bio-
informatics approaches before heading into the labora-
tory. The BioHealthBase places signiﬁcant emphasis
on supporting data related to host–pathogen interactions
in order to gain a better understanding of the nature
of virulence and host range, and the impact of sequence
variation on these phenomena. Current plans for
future enhancements of the BioHealthBase BRC
resource include the ability to construct phylogenetic
trees based on sequence relationships, the deﬁnition of
functional sequence features in inﬂuenza proteins
and their availability for display in both the genome
browser and the 3D protein structure visualization
module, and the support for surveillance and research
data produced by the Centers of Excellence for Inﬂuenza
Research and Surveillance program recently funded by
NIAID (http://www3.niaid.nih.gov/research/resources/
ceirs/).
Figure 4. 3D Protein structure visualization. A ball-and-stick representation of the RNA-binding domain of the NS1 protein dimer
from the A/Udorn/307/1972 (PDB ID 1NS1) is shown. RNA-binding residues aa38 and aa41 are highlighted in red, while the single
amino acid diﬀerence between DkXi22 and DkXi35at aa66 is highlighted in blue. RNA binds parallel to the plane on top of the red RNA-binding
residues.
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Supplementary Data are available at NAR Online.
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